Replies to post #72192 on ViaDerma Inc (VDRM)

[Fasctrack]

Thanks GC. Not sure what to make of the arrangement (whether it's good deal for VDRM). Sounds like Biogenx will fund the costs of production, distribution and marketing of VitaStem. Then split the gross profit from sales 50/50 with VDRM. Sounds like Biogenx will be taking all of the risk. We'll see. At this point we are at the Doc's mercy. Over simplifying here, but if they produce and the stock price goes up, I'll be happy. As we have seen, its a big IF. Still holding.